导师基本信息
- 姓名：邢宝才
- 性别：男
- 民族：汉族
- 科室：肝胆胰外科-I
- 职称：主任医师,教授
- 专业：肿瘤学、肿瘤外科学
- E-MAIL： xingbaocai88@sina.com
学术论文 | 奖励表彰 | 研究方向 | 科研项目 | 招生计划
Wang YY#, Xiang BD#, Ma L, Zhong JH, Ye JZ, Wang K, Xing BC* and Li LQ*. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma,Ann Surg,Online ahead of print.
Jin KM, Liu W, Wang K, Bao Q, Wang HW and Xing BC*. The individualized selection of Pancreaticoenteric anastomosis in Pancreaticoduodenectomy,BMC Surg,2020, 20(1): 140.
Liu X, Xu D, Liu Z, Li Y, Zhang C, Gong Y, Jiang Y and Xing B*. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition,Clin Transl Oncol,Online ahead of print.
Wang LJ, Wang HW, Jin KM, Li J and Xing BC*. Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases,BMC Surg,2020, 20(1): 16.
Wang LJ, Yan XL, Li J, Wang K and Xing BC*. Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis,Cancer Manag Res,2020, 12: 3237-3245.
Liu W, Wang HW, Wang K and Xing BC*. The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis,Eur J Surg Oncol,45(8):1349-1356.
Liu W, Wang K, Han Y, Liang JY, Li YH and Xing BC*. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection,Eur J Surg Oncol,45(11):2070-2077.
Liu Z, Liu X, Li Y, Ren P, Zhang C, Wang L, Du X* and Xing B*. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression,Cancer Manag Res,2019,11:5317-5332.
Ren P, Sun X, Zhang C, Wang L, Xing B* and Du X*. Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer,Biochem Biophys Res Commun,512(4):871-876.
Wang J#, Xing B#, Liu W, Li J, Wang X, Li J, Yang J, Ji C, Li Z, Dong B, Gao J and Shen L. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis,Theranostics,9(12): 3485-3500.
Wang YY, Liu ZZ, Xu D, Liu M, Wang K and Xing BC*. Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases,Ann Surg Oncol,26(11):3682-3692.
Wang YY, Wang LJ, Xu D, Liu M, Wang HW, Wang K, Zhu X, Xing BC*. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion,HPB (Oxford),21(4):425-433.
Jiang Y#, Sun A#, Zhao Y#, Ying W#, Sun H#, Yang X#, Xing B#, Sun W, Ren L, Hu B, Li C, Zhang L, Qin G, Zhang M, Chen N, Zhang M, Huang Y, Zhou J, Zhao Y, Liu M, Zhu X, Qiu Y, Sun Y, Huang C, Yan M, Wang M, Liu W, Tian F, Xu H, Zhou J, Wu Z, Shi T, Zhu W, Qin J, Xie L, Fan J, Qian X, He F. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma,Nature,567(7747):257-261.
Wang YY, Zhong JH, Mao YL, Li LQ, Xing BC*. Editorial: redrawing the boundaries for surgical intervention in hepatocellular carcinoma-authors' reply,Aliment Pharmacol Ther,49(5):616-617.
Xu D, Wang HW, Yan XL, Li J, Wang K, Xing BC*. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases,Eur J Surg Oncol,45(9):1551-1558.
Wang YY, Zhong JH, Xu HF, Xu G, Wang LJ, Xu D, Wang HW, Wang K, Xiang BD, Mao YL*, Li LQ*, Xing BC*. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria,Aliment Pharmacol Ther,49(2):202-210.
Zhang J, Ren P, Xu D, Liu X, Liu Z, Zhang C, Li Y, Wang L, Du X*, Xing B*. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc,Cancer Lett,440-441:106-115.
2022年北京大学优秀博士学位论文指导教师, 北京大学优秀博士学位论文指导教师, 第1完成人, 北京大学, 2022.9
北京大学医学部2021年住院医师/专科医师规范化培训学科组优秀个人, 住院医师/专科医师规范化培训学科组优秀个人, 第1完成人, 北京大学医学部, 2021.9
肝癌临床样本库建设, 子课题负责人, 2018.11.1～2020.12.31, 科技重大专项重大传染病防治专项（A001838）
肝癌精准近红外荧光成像术中导航系统的临床应用, 课题负责人, 2019.12.1～2021.12.31, 国家重点研发计划
一个核仁蛋白在小鼠胚胎成血成血管和人肿瘤血管新生中的作用及机制研究, 课题负责人, 2019.1.1～2022.12.31, 国家自然科学基金委
hUTP14a通过调节血管生成促进结直肠癌转移, 课题负责人, 2019.1.1～2021.12.31, 北京市自然科学基金
肝动脉灌注化疗联合系统化疗用于结直肠癌肝转移术后辅助治疗的多中心前瞻性随机对照临床研究, 子课题负责人, 2018.1.1～2020.12.31, 首都卫生发展科研专项
